RecruitingNCT04754217

Valved Graft PMCF Study

Valved Graft Post-Market Clinical Follow-up Study

Sponsor

Abbott Medical Devices

Enrollment

260 participants

Start Date

Jul 13, 2021

Study Type

OBSERVATIONAL

Conditions

Aortic Valve Disease Aortic Dissection Ascending Aorta Abnormality

Summary

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called CAVGJ and a medical device called VAVGJ for people with aortic dissection, aortic valve disease, and other related conditions. The study is currently recruiting participants at 25 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVAVGJ

Replacement of the aortic valve and ascending aorta

DEVICECAVGJ

Replacement of the aortic valve and ascending aorta

Locations(25)

University Hospital - Univ. of Alabama at Birmingham (UAB)

Birmingham, Alabama, United States

University of Michigan

Ann Arbor, Michigan, United States

Mission Health & Hospitals

Asheville, North Carolina, United States

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Klinik Floridsdorf

Vienna, Austria

Rigshospitalet

Copenhagen, Denmark

CHU de Besancon - Jean Minjoz

Besançon, France

CHRU Lille

Lille, France

Groupe Hospitalier Bichat - Claude Bernard

Paris, France

Herz-und Diabetes Zentrum NRW

Bad Oeynhausen, Germany

Deutsches Herzzentrum Berlin

Berlin, Germany

Klinikum Links der Weser

Bremen, Germany

Medizinische Hochschule Hannover

Hanover, Germany

Onassis Cardiac Surgery Center

Athens, Greece

Policlinico S.Orsola-Malpighi

Bologna, Italy

Ospedale San Raffaele

Milan, Italy

Policlinico San Donato

San Donato Milanese, Italy

Wojewodzki Szpital Zespolony w Kielcach

Kielce, Poland

Krakowski Szpital Specjalistyczny im. Jana Pawla II

Krakow, Poland

Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi

Lodz, Poland

The Cardinal Stefan Wyszynski Institute of Cardiology

Warsaw, Poland

Hospital Universitario del Vinalopó

Elche, Spain

Hospital Universitario Son Espases

Palma de Mallorca, Spain

James Cook University Hospital

Middlesbrough, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04754217

Related Trials

CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation

NCT070089111 location

KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance

NCT076198721 location

PregnAncy-Related Aortic DISsEction in China

NCT076722104 locations

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

NCT0682799018 locations

CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

NCT072767113 locations